Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Breast Neoplasms 145Carcinoma, Intraductal, Noninfiltrating 12Breast Carcinoma In Situ 10Neoplasm Metastasis 9Breast Neoplasms, Male 9Neoplasms 5Ovarian Neoplasms 4Prostatic Neoplasms 3Inflammatory Breast Neoplasms 3Gliosarcoma 3Glioma 3Glioblastoma 3Fallopian Tube Neoplasms 3Endometrial Neoplasms 3Central Nervous System Neoplasms 3Carcinoma, Ductal, Breast 3Brain Neoplasms 3Urinary Bladder Neoplasms 2Sarcoma 2Oligodendroglioma 2Multiple Endocrine Neoplasia Type 1 2Liver Neoplasms 2Hot Flashes 2Glioma, Subependymal 2Fibroadenoma 2Ependymoma 2Carcinoma, Ovarian Epithelial 2Carcinoma, Hepatocellular 2Astrocytoma 2Thyroid Neoplasms 1

Interventions

bicalutamide 2mirabegron 1Transcutaneous Electric Nerve Stimulation 1Tamoxifen 1Leuprolide 1Dutasteride 1Doxazosin 1Celecoxib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Lower Urinary Tract Symptoms × Tamoxifen × Clear all
NCT00866554 2023-06-02

Efficacy and Toxicity of Bicalutamide and Dutasteride vs. Standard Care for Prostate Cytoreduction for Brachytherapy

CHU de Quebec-Universite Laval

Phase 2 Completed
60 enrolled
Genitourinary

Erectile Dysfunction, Prostatic Neoplasms, Lower Urinary Tract Symptoms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡